Real World Experience of Drug Induced Liver Injury in Patients Undergoing Chemotherapy
Author(s) -
Adiba Azad,
Paul Chang,
Deepika Devuni,
Kian Bichoupan,
Varun Kesar,
Andrea D. Branch,
William Oh,
Matthew D. Galsky,
Jawad Ahmad,
Joseph A. Odin
Publication year - 2018
Publication title -
journal of clinical gastroenterology and hepatology
Language(s) - English
Resource type - Journals
ISSN - 2575-7733
DOI - 10.21767/2575-7733.1000047
Subject(s) - medicine , incidence (geometry) , chemotherapy , retrospective cohort study , cumulative incidence , population , liver injury , drug , epidemiology , surgery , gastroenterology , pharmacology , cohort , optics , physics , environmental health
To better understand the clinical significance of drug induced liver injury (DILI) during chemotherapy, we examined the epidemiology, incidence, and treatment effects of DILI in patients undergoing chemotherapy for genitourinary malignancies over a two-year period.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom